PEGylated Lipid Nanoparticle Formulations: Immunological Safety and Efficiency Perspective

Abstract

Lipid nanoparticles (LNPs) have been recognized as efficient vehicles to transport a large variety of therapeutics. Currently in the spotlight as important constituents of the COVID-19 mRNA vaccines, LNPs play a significant role in protecting and transporting mRNA to cells. As one of their key constituents, polyethylene glycol (PEG)−lipid conjugates are important in defining LNP physicochemical characteristics and biological activity. PEGylation has proven particularly efficient in conferring longer systemic circulation of LNPs, thus greatly improving their pharmacokinetics and efficiency. Along with revealing the benefits of PEG conjugates, studies have revealed unexpected immune reactions against PEGylated nanocarriers such as accelerated blood clearance (ABC), involving the production of anti-PEG antibodies at initial injection, which initiates accelerated blood clearance upon subsequent injections, as well as a hypersensitivity reaction referred to as complement activation-related pseudoallergy (CARPA). Further, data have been accumulated indicating consistent yet sometimes controversial correlations between various structural parameters of the PEG−lipids, the properties of the PEGylated LNPs, and the magnitude of the observed adverse effects. Detailed knowledge and comprehension of such correlations are of foremost importance in the efforts to diminish and eliminate the undesirable immune reactions and improve the safety and efficiency of the PEGylated medicines. Here, we present an overview based on analysis of data from the CAS Content Collection regarding the PEGylated LNP immunogenicity and overall safety concerns. A comprehensive summary has been compiled outlining how various structural parameters of the PEG−lipids affect the immune responses and activities of the LNPs, with regards to their efficiency in drug delivery. This Review is thus intended to serve as a helpful resource in understanding the current knowledge in the field, in an effort to further solve the remaining challenges and to achieve full potential.

Optimized Design of Hyaluronic Acid–Lipid Conjugate Biomaterial for Augmenting CD44 Recognition of Surface-Engineered NK Cells

“…As our surface modulation strategy relies on hydrophobic interactions between the cell membrane and the amphiphilic conjugate, the interaction is likely influenced by both PEG length and DS level of the lipid–PEG moiety in the HA backbone. Specifically, the length of PEG could regulate (1) internalization of materials into the cell, often observed with lower MW of PEG, and (2) inhibition of interaction between cells and materials with a higher MW of PEG. − This phenomenon has been shown in various studies. For instance, previous research has demonstrated that approximately a half-permeability of PEG 1.5k into mesenchymal stem cells was obtained than the internalization level of PEG 0.6k .…”

Optimized synthesis of functional organosilicon monomers and polymers exploiting new types of CuAAC recoverable heterogeneous catalysts

“…72 In turn, copolymers based on PEG and OEG, as well as PEGlylated particles or dendrimers of various natures, are of great importance in biomedicine and other applications. [73][74][75][76][77] Therefore, in our work we wanted to demonstrate the possibility of introducing oligomeric ethylene oxide fragments (triethylene glycol monopropargyl ether (mTEG)) into the shell of a carbosilane dendrimer by azide-alkyne cycloaddition on a heterogeneous catalyst, which has also not been done previously.…”

Therapeutic synthetic and natural materials for immunoengineering

“…DMG-PEG 2000 and ALC-0159 are the PEGylated lipids used in Modernas elasomeran and Pfizer-BioNTechs tozinameran COVID-19 vaccines, respectively. 208…”